Introduction {#s1}
============

Variants in genes encoding voltage-gated sodium (Na~V~) channels are associated with epilepsy and neurodevelopmental disorders with a wide range of severity ([@bib13]; [@bib39]). This is illustrated by variants in *SCN2A* encoding the Na~V~1.2 channel, which may be associated with relatively benign familial epilepsy ([@bib18]; [@bib5]; [@bib17]; [@bib33]), early-onset epileptic encephalopathy (EOEE; [@bib2]; [@bib35]; [@bib49]; [@bib19]; [@bib53]), autism spectrum disorder ([@bib36]; [@bib43]; [@bib8]; [@bib3]), or intellectual disability ([@bib1]; [@bib42]). One of the most severe conditions associated with *SCN2A* mutation is Ohtahara syndrome, which has onset within the first 2 wk of life and features intractable focal or generalized seizures sometimes accompanied by a suppression-burst pattern on electroencephalography (EEG), eventually manifesting with severe cognitive and neurodevelopmental impairment ([@bib26]; [@bib35]; [@bib49]; [@bib58]). The factors contributing to the very early onset and severity of Ohtahara syndrome and related disorders associated with Na~V~1.2 variants are not entirely clear ([@bib37]).

Previous reports have suggested that the majority of EOEE-associated Na~V~1.2 variants exert gain-of-function effects ([@bib3]; [@bib4]), although only a few variants have been studied. Because Na~V~1.2 is strongly expressed in neocortical glutamatergic pyramidal neurons, where it localizes to axon initial segments (AISs), nodes of Ranvier, and the somatodendritic compartment in the developing brain, gain-of-function variants are predicted to enhance network excitability ([@bib21]; [@bib27]; [@bib48]; [@bib55]; [@bib45]). During maturation, Na~V~1.2 is replaced at the distal AIS and nodes of Ranvier by Na~V~1.6, suggesting that gain-of-function variants in Na~V~1.2 may have less severe consequences on action potential initiation and propagation in mature neurons due to its diminished contribution to these processes ([@bib21]; [@bib27]; [@bib48]). Consistent with this developmental switch in Na~V~ channel expression, recent work has suggested that sodium channel--blocking antiepileptic drugs are most effective in the setting of EOEE associated with gain-of-function Na~V~1.2 variants ([@bib53]).

*SCN2A* undergoes developmentally regulated alternative mRNA splicing that leads to incorporation of an alternate exon encoding a portion of the domain I voltage-sensor (S3 and S4 helices). The two resulting protein isoforms (proteoforms) differ by one amino acid at position 209, encoding an asparagine in the splice proteoform expressed primarily during early development (neonatal proteoform, designated here as Na~V~1.2N) and an aspartic acid in the proteoform expressed mainly in adult brain (Na~V~1.2A). While this splicing event has been demonstrated in human brain tissue, the time course over which the transition from neonatal to adult proteoforms occurs is unknown ([@bib25]). In mouse cortex, the neonatal splice proteoform is present in approximately twofold excess compared with the canonical adult-expressed Na~V~1.2A transcript in early development, but drops to one third of the canonical splice proteoform within the first 2 wk of life ([@bib25]; [@bib7]; [@bib12]). An analogous splicing event affecting Na~V~1.1 influences the pharmacological properties of that channel ([@bib46]). The contribution of alternative splicing to the pathogenesis of *SCN2A*-associated EOEE has not been systematically investigated, and prior studies determining the functional consequences of *SCN2A* variants were performed using the canonical splice proteoform expressed predominantly in adult brain ([@bib33]; [@bib3]; [@bib53]; [@bib4]). However, some work suggests that variants in the neonatal splice proteoform negatively impact neuronal excitability ([@bib54]; [@bib11]).

In this study, we examined the functional consequences of five Na~V~1.2 variants (T236S, E999K, S1336Y, T1623N, and R1882Q) in both the neonatal and adult proteoforms. Four of the five variants were not previously studied for their functional effects, while R1882Q was previously shown to exhibit a depolarized shift in voltage dependence of inactivation and slowed onset of inactivation compared with WT channels ([@bib4]; [@bib32]). However, none of the variants have been studied in the two splice isoforms. We demonstrate that Na~V~1.2 variants associated with EOEE exhibit greater dysfunction when expressed in the neonatal splice proteoform. Our results indicate that both developmentally regulated alternative mRNA splicing of Na~V~1.2 and developmental stage are important factors promoting neuronal hyperexcitability. These observations have implications for understanding the pathophysiology of EOEE and for guiding experimental strategies to determine the functional consequences of Na~V~ channel variants associated with these life-threatening, early-life neurodevelopmental disorders.

Materials and methods {#s2}
=====================

Mutagenesis and heterologous expression of Na~V~1.2 {#s3}
---------------------------------------------------

Mutagenesis of recombinant human Na~V~1.2 was performed as described previously ([@bib31]; [@bib41]; [@bib24]; [@bib46]). To generate the neonatal splice isoform (Na~V~1.2N), a single substitution (D209N) was introduced. Five EOEE-associated variants (T236S, E999K, S1336Y, T1623N, and R1882Q) were introduced into both Na~V~1.2N and Na~V~1.2A splice isoforms. To minimize spontaneous mutagenesis of Na~V~1.2 cDNA in bacteria, recombinants were always propagated in Stbl2 cells (Invitrogen) at 30°C.

Heterologous expression of WT or Na~V~1.2 variants was performed in tsA201 cells. Heterologous expression in tsA201 cells was chosen for these experiments to enable precise measurement of biophysical parameters associated with WT or mutant Na~V~1.2 channels, without the contamination of other sodium currents that may be found in native neuronal cells. Cells were grown in 5% CO~2~ at 37°C in Dulbecco's modified Eagle's medium supplemented with 10% FBS, 2 mM [l]{.smallcaps}-glutamine, 50 units/ml penicillin, and 50 µg/ml streptomycin. Cells were transiently cotransfected with Na~V~1.2 and the accessory β~1~ and β~2~ subunits (2 µg total plasmid DNA was transfected with a cDNA ratio of 10:1:1 for Na~V~1.2:β~1~:β~2~ subunits) using SuperFect reagent (Qiagen). Human β~1~ and β~2~ cDNAs were cloned into plasmids encoding the CD8 receptor (CD8-IRES-hβ~1~) or enhanced GFP-IRES-hβ~2~, respectively, as transfection markers, as previously described.

Voltage-clamp recording and data analysis {#s4}
-----------------------------------------

Whole-cell voltage clamp experiments of heterologous cells were performed as previously described ([@bib46], [@bib47]). Whole-cell voltage-clamp recordings were made at room temperature using an Axopatch 200B amplifier (Molecular Devices). Patch pipettes were pulled from borosilicate glass capillaries (Harvard Apparatus) with a multistage P-1000 Flaming-Brown micropipette puller (Sutter Instruments) and fire-polished using a microforge (Narashige MF-830) to a resistance of 1.5--2.5 MΩ. The pipette solution consisted of (in mM): 10 NaF, 105 CsF, 20 CsCl, 2 EGTA, and 10 HEPES, with pH adjusted to 7.35 with CsOH and osmolality adjusted to 300 mOsmol/kg with sucrose. The recording solution was continuously perfused with bath solution containing (in mM): 145 NaCl, 4 KCl, 1.8 CaCl~2~, 1 MgCl~2~, 10 glucose, and 10 HEPES, with pH 7.35 and osmolality 310 mOsmol/kg. The reference electrode consisted of a 2% agar bridge with composition similar to the bath solution. All chemicals were purchased from Sigma-Aldrich.

Voltage-clamp pulse generation and data collection were done using Clampex 10.4 (Molecular Devices). Whole-cell capacitance was determined by integrating capacitive transients generated by a voltage step from −120 mV to −110 mV filtered at 100 kHz low-pass Bessel filtering. Series resistance was compensated with prediction \>70% and correction \>90% to ensure that the command potential was reached within microseconds with a voltage error \<3 mV. Leak currents were subtracted by using an online P/4 procedure. All whole-cell currents were filtered at 5 kHz low-pass Bessel filtering and digitized at 50 kHz. All voltage-clamp experiments were conducted at room temperature (20--25°C).

Data were analyzed using a combination of Clampfit 10.4 (Molecular Devices), Excel 2013 (Microsoft), and SigmaPlot 12.5 (Systat Software). Peak current was normalized for cell capacitance and plotted against step voltage to generate a peak current density--voltage relationship. Whole-cell conductance (G~Na~) was calculated as G~Na~ = *I*/(*V* − *E~rev~*), where *I* is the measured peak current, *V* is the step potential, and *E~rev~* is the calculated sodium reversal potential. G~Na~ at each voltage step was normalized to the maximum conductance between −80 mV and 20 mV. To calculate voltage dependence of activation (protocol described in figure insets), normalized G~Na~ was plotted against voltage and fitted with the Boltzmann function *G*/*G~max~* = (1 + exp\[(*V* -- *V*~1/2~)/*k*\])^−1^, where *V*~1/2~ indicates the voltage at half-maximal activation, and *k* is a slope factor describing voltage sensitivity of the channel. Voltage dependence of steady-state inactivation was assessed by plotting currents generated by the −10-mV postpulse voltage step normalized to the maximum current against prepulse voltage step from −140 to −10 mV in 10-mV increments. The plot was fitted with the Boltzmann function. Time-dependent recovery from inactivation was evaluated by fitting peak current recovery with a two-exponential function. Chord conductance at 0 mV (20 trials from a holding potential of −120 mV) was determined using non-stationary fluctuation analysis where σ^2^(*I*) − *iI* − (*I*^2^/*N*), where σ^2^ is variance, *i* is single-channel current, *I* is average current, and *N* is number of channels.

Results are presented as mean ± SEM. The statistical tests performed are specified in the figure legends. P \< 0.05 was considered statistically significant.

Computational modeling {#s5}
----------------------

Simulations were performed using a pyramidal cell model in the NEURON environment, as previously described ([@bib44]; [@bib16]; [@bib3]; [@bib45]). All EOEE syndrome variants were modeled as changes relative to this baseline. All Na~V~ channel simulations were performed at 25°C to match recording conditions. All neuronal simulations were performed at 33°C, with kinetics scaled by the Q~10~ factor within the model. Because changes in whole-cell current densities may be a byproduct of expression system, we only modeled changes in sodium channel biophysical parameters. All neuronal simulations assumed heterozygosity. Model files will be provided upon request to the author.

Results {#s6}
=======

Developmentally regulated alternative mRNA splicing is a conserved feature of human Na~V~ channels. In human Na~V~1.2, alternative splicing involves a pair of mutually exclusive exons encoding part of S3 and S4 in domain I and generates two channel proteoforms (designated Na~V~1.2-neonatal \[Na~V~1.2N\] and Na~V~1.2-adult \[Na~V~1.2A\]) that differ by a single amino acid residue (adult to neonatal: D209N, [Fig. 1 A](#fig1){ref-type="fig"}). We compared the functional properties of heterologously expressed WT Na~V~1.2N and Na~V~1.2A proteoforms. Total whole-cell current density, voltage dependence of channel inactivation, and recovery from fast inactivation were not significantly different between the two WT Na~V~1.2 proteoforms ([Fig. 1](#fig1){ref-type="fig"}). However, Na~V~1.2N exhibited a significantly depolarized voltage dependence of activation compared with Na~V~1.2A (activation *V*~1/2~: WT-Na~V~1.2N, −19.6 ± 0.8 mV; Na~V~1.2A, −23.5 ± 1.3 mV, *n* = 15; P = 0.0172; [Fig. 1 D](#fig1){ref-type="fig"}). This depolarized voltage dependence of activation may limit neuronal excitability during early development ([@bib54]; [@bib11]).

![**Biophysical properties of Na~V~1.2 splice variants.** **(A)** Top: Predicted transmembrane topology of Na~V~1.2, highlighting the location of the exon 5 coding region (black shaded) and amino acid change associated with alternative exon splicing (black dot). Bottom: Amino acid alignment of Na~V~1.2N and Na~V~1.2A. **(B)** Representative whole-cell sodium currents recorded from tsA201 cells coexpressing either Na~V~1.2N (left) or Na~V~1.2A (right) with β1 and β2 subunits. **(C)** Current density elicited by test pulses to various membrane potentials and normalized to cell capacitance. **(D)** Voltage dependence of channel activation. **(E)** Voltage dependence of channel inactivation. **(F)** Time-dependent recovery from inactivation. Closed symbols represent Na~V~1.2A, and open symbols represent Na~V~1.2N. All data are expressed as mean ± SEM for 15 measurements. Statistical comparisons were made using an unpaired Student's *t* test.](JGP_201912442_Fig1){#fig1}

Biophysical properties of epileptic encephalopathy--associated Na~V~1.2 variants {#s7}
--------------------------------------------------------------------------------

We investigated the functional consequences of five EOEE-associated Na~V~1.2 variants. Four variants, reported originally by [@bib35], were identified in neonates having seizures associated with a suppression-burst EEG pattern beginning within the first week of life (age 0--1 d for three variants, age 6 d for E999K). Three of the subjects were described as having medically intractable epilepsy (an exception was the carrier of T236S, who responded to a four-antiepileptic-drug regimen), and all had severe developmental delay. The initial diagnosis was Ohtahara syndrome in all cases, but three were later reclassified as West syndrome due to emergence of hypsarrhythmia on EEG. The other variant, R1882Q, is recurrent and presents with focal seizures on the first day of life that evolves to severe developmental delay ([@bib19]). These variants were specifically chosen because the associated clinical phenotypes had very early onset, and they were also chosen to represent each domain of the sodium channel.

We first examined whole-cell sodium current density for WT and mutant Na~V~1.2N. Current density for Na~V~1.2N-E999K, Na~V~1.2N-T1623N, and Na~V~1.2N-R1882Q was not statistically different from WT. However, T236S expressed in Na~V~1.2N had approximately twofold larger currents than the WT channel (Na~V~1.2N-WT: −480.9 ± 60.9 pA/pF, *n* = 15; Na~V~1.2N-T236S: −985.9 ± 184.8 pA/pF, *n* = 15, P = 0.0037; [Fig. 2, B and C](#fig2){ref-type="fig"}; and [Fig. 3](#fig3){ref-type="fig"}). We calculated chord conductance at 0 mV using non-stationary fluctuation analysis and found no difference between NaV1.2N-WT and NaV1.2N-T236S (19.9 ± 4.4 vs. 23.4 ± 3.4 pS, respectively, *n* = 5 each, P = 0.75). Also, we observed a strong trend toward smaller current density compared with WT Na~V~1.2N for Na~V~1.2N-S1336Y (−113.7 ± 26.9 pA/pF, *n* = 10, P = 0.0549). Similar to that of the neonatal isoform, neither Na~V~1.2A-E999K, Na~V~1.2A-Na~V~1.2A-T1623N, nor Na~V~1.2A-R1882Q showed any alterations in current density. The Na~V~1.2A-S1336Y variant showed similarly small currents compared with the neonatal isoform of the channel (−104.7 ± 14.7 pA/pF, *n* = 11, P = 0.0045; [Fig. 2, B and C](#fig2){ref-type="fig"}; and [Fig. 3](#fig3){ref-type="fig"}). However, the larger current density observed for Na~V~1.2N-T236S was not evident in the adult isoform (WT Na~V~1.2A: −518.4 ± 50.9 pA/pF, *n* = 15; Na~V~1.2A-T236S: −405.2 ± 83.9 pA/pF, *n* = 9, P = 0.87; [Fig. 2, B and C](#fig2){ref-type="fig"}; and [Fig. 3](#fig3){ref-type="fig"}).

![**Function of EOEE-associated variants.** **(A)** Predicted transmembrane topology of Na~V~1.2, highlighting the location of the exon 5 coding region (black shaded), amino acid change associated with alternative exon splicing (black dot), and EOEE-associated variants (colored dots). **(B)** Whole-cell sodium currents of EOEE-associated Na~V~1.2 variants in either the adult (Na~V~1.2N; left) or neonatal (Na~V~1.2A; right) splice isoforms. **(C)** Peak current density elicited by test pulses to 0 mV from a holding potential of −120 mV for Na~V~1.2N (open bars) and Na~V~1.2A (closed bars) proteoforms. All data are expressed as mean ± SEM for 8--15 measurements. \*, P \< 0.05 compared with Na~V~1.2A; ^‡^, P \< 0.05 Na~V~1.2N. EOEE-associated variants were compared with WT Na~V~1.2 of the same proteoform using a one-way ANOVA, followed by Dunnett's post hoc test.](JGP_201912442_Fig2){#fig2}

![**The impact of Na~V~1.2 alternative splicing on sodium current density.** **(A and B)**Current--voltage relationships for WT and EOEE-associated variants expressed in the neonatal (A) or adult (B) Na~V~1.2 splice isoforms. All data are expressed as mean ± SEM for 8--15 measurements.](JGP_201912442_Fig3){#fig3}

We determined if the variants altered the voltage dependence of channel activation. We observed that Na~V~1.2N-T236S, Na~V~1.2N-E999K, and Na~V~1.2N-S1336Y all had hyperpolarized voltage dependence of activation compared with WT Na~V~1.2N (Na~V~1.2N: −19.6 ± 0.8 mV, *n* = 15; Na~V~1.2N-T236S: −29.9 ± 1.1 mV, *n* = 15, P \< 0.0001; Na~V~1.2N-E999K: −26.7 ± 1.7 mV, *n* = 14, P = 0.003; Na~V~1.2N-S1336Y: −25.3 ± 1.9 mV, *n* = 10, P = 0.0278; [Fig. 4](#fig4){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}). However, when voltage dependence of activation was measured in the adult isoform, we found that the mutants were indistinguishable from WT Na~V~1.2A (WT-Na~V~1.2A: −23.5 ± 1.3 mV, *n* = 15; Na~V~1.2A-T236S: −25.6 ± 2.0 mV, *n* = 9, P = 0.78; Na~V~1.2A-E999K: −24.6 ± 1.4 mV, *n* = 10, P = 0.96; Na~V~1.2A-S1336Y: −23.2 ± 1.4 mV, *n* = 11, P = 0.99; [Fig. 4](#fig4){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}). Interestingly, in Na~V~1.2A, we observed a depolarized shift in the voltage dependence of activation for T1623N (−18.4 ± 1.4 mV, *n* = 8, P = 0.0316; [Fig. 4](#fig4){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}). These results suggest that three variants, T236S, E999K, and S1336Y, may confer neuronal hyperexcitability, but only when expressed in Na~V~1.2N.

![**Alternative splicing of Na~V~1.2 differentially modulates the effect of EOEE-associated variants on channel activation. (A and B)** Voltage dependence of activation for WT and EOEE-associated Na~V~1.2 variants in the neonatal (A) or adult (B) proteoform. **(C and D)**Values for V~1/2~ of activation for WT and EOEE-associated Na~V~1.2 variants in the neonatal (C) or adult (D) proteoform. All data are expressed as mean ± SEM for 8--15 measurements. EOEE-associated variants were compared with WT Na~V~1.2 of the same proteoform using one-way ANOVA, followed by Dunnett's post hoc test. \*\*\*, P \< 0.0001; \*\*, P \< 0.01; \*, P \< 0.05.](JGP_201912442_Fig4){#fig4}

###### Biophysical properties of Na~V~1.2 variants

  Variant            Voltage dependence of activation             Voltage dependence of fast inactivation    Recovery from fast inactivation (−10 mV)                                                                                                                                                        
  ------------------ -------------------------------------------- ------------------------------------------ ------------------------------------------ -------------------------------------------- ------------------------------------------- ---- ------------------------- ---------------------------- ----
  Na~V~1.2A          −23.5 ± 1.3                                  6.3 ± 0.3                                  15                                         −63.5 ± 0.9                                  −6.2 ± 0.1                                  15   1.9 ± 0.1 (0.90 ± 0.01)   275.6 ± 16.4 (0.12 ± 0.01)   15
  Na~V~1.2A-T236S    −25.6 ± 2.0                                  7.0 ± 0.3                                  9                                          −65.3 ± 1.8                                  −5.6 ± 0.1                                  9    2.1 ± 0.1 (0.87 ± 0.01)   270.1 ± 16.8 (0.14 ± 0.01)   8
  Na~V~1.2A-E999K    −4.6 ± 1.4                                   6.5 ± 0.3                                  10                                         −63.1 ± 1.2                                  −6.2 ± 0.1                                  10   1.9 ± 0.2 (0.90 ± 0.01)   269.3 ± 21.2 (0.14 ± 0.01)   10
  Na~V~1.2A-S1336Y   −23.2 ± 1.4                                  7.9 ± 0.4                                  11                                         −57.7 ± 1.3[a](#t1n1){ref-type="table-fn"}   −6.6 ± 0.3                                  11   1.3 ± 0.2 (0.84 ± 0.03)   210.3 ± 20.4 (0.21 ± 0.02)   11
  Na~V~1.2A-T1623N   −18.4 ± 1.4[a](#t1n1){ref-type="table-fn"}   6.4 ± 0.6                                  8                                          −56.7 ± 0.8[a](#t1n1){ref-type="table-fn"}   −6.0 ± 0.1                                  8    2.1 ± 0.1 (0.92 ± 0.01)   240.4 ± 17.4 (0.09 ± 0.01)   8
  Na~V~1.2A-R1882Q   −19.5 ± 0.9                                  6.7 ± 0.3                                  15                                         −51.2 ± 1.5[a](#t1n1){ref-type="table-fn"}   −7.6 ± 0.3[a](#t1n1){ref-type="table-fn"}   15   1.6 ± 0.1 (0.84 ± 0.02)   248.2 ± 22.0 (0.16 ± 0.02)   15
  Na~V~1.2N          −19.5 ± 0.8[b](#t1n2){ref-type="table-fn"}   7.0 ± 0.3                                  15                                         −62.4 ± 1.2                                  −6.4 ± 0.1                                  15   1.7± 0.1 (0.90 ± 0.01)    267.3 ± 28.8 (0.13 ± 0.01)   15
  Na~V~1.2N-T236S    −29.9 ± 1.1[a](#t1n1){ref-type="table-fn"}   5.7 ± 0.4[a](#t1n1){ref-type="table-fn"}   15                                         −62.3 ± 0.8                                  6.1 ± 0.4                                   8    1.9 ± 0.1 (0.87 ± 0.01)   245.3 ± 7.7 (0.14 ± 0.01)    7
  Na~V~1.2N-E999K    −26.2 ± 1.7[a](#t1n1){ref-type="table-fn"}   6.3 ± 0.4                                  14                                         −63.1 ± 1.3                                  −5.8 ± 0.1                                  13   1.8 ± 0.1 (0.89 ± 0.01)   263.2 ± 22.9 (0.12 ± 0.01)   13
  Na~V~1.2N-S1336Y   −25.3 ± 1.9[a](#t1n1){ref-type="table-fn"}   7.3 ± 0.7                                  10                                         −56.9 ± 1.0[a](#t1n1){ref-type="table-fn"}   −7.9 ± 0.8[a](#t1n1){ref-type="table-fn"}   10   1.0 ± 0.1 (0.89 ± 0.02)   261.0 ± 38.8 (0.16 ± 0.03)   10
  Na~V~1.2N-T1623N   −18.4 ± 1.4                                  6.2 ± 0.3                                  9                                          −56.3 ± 0.7[a](#t1n1){ref-type="table-fn"}   −6.3 ± 0.4                                  9    2.0 ± 0.1 (0.87 ± 0.02)   213.6 ± 23.9 (0.14 ± 0.02)   9
  Na~V~1.2N-R1882Q   −20.6 ± 1.7                                  6.2 ± 0.4                                  14                                         −53.4 ± 1.3[a](#t1n1){ref-type="table-fn"}   −7.0 ± 0.2[a](#t1n1){ref-type="table-fn"}   14   1.6 ± 0.1 (0.88 ± 0.02)   258.2 ± 27.8 (0.12 ± 0.02)   14

P \< 0.05 between WT and variant in same splice isoform.

P \< 0.05 between neonatal and adult isoforms.

We investigated whether the variants exhibited a compensatory hyperpolarization in the voltage dependence of inactivation when expressed in Na~V~1.2N. We found that both T236S and E999K were indistinguishable from WT Na~V~1.2N (WT-Na~V~1.2N: −62.4 ± 1.2 mV, *n* = 15; Na~V~1.2N-T236S: −62.3 ± 0.8 mV, *n* = 8, P = 0.999; Na~V~1.2N-E999K: −63.1 ± 1.3 mV, *n* = 13, P = 0.992; [Fig. 5](#fig5){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}). However, Na~V~1.2N-S1336Y, Na~V~1.2N-T1623N, and Na~V~1.2N-R1882Q all showed a depolarized shift in the voltage dependence of inactivation (Na~V~1.2N-S1336Y: −56.9 ± 1.0 mV, *n* = 10, P = 0.0075; Na~V~1.2N-T1623N: −56.3 ± 0.7 mV, *n* = 9, P = 0.0049; Na~V~1.2N-R1882Q: −53.4 ± 1.3 mV, *n* = 14, P \< 0.0001; [Fig. 5, A and C](#fig5){ref-type="fig"}; and [Table 1](#tbl1){ref-type="table"}). These differences in voltage dependence of inactivation were proteoform independent, with similar depolarized shifts observed in Na~V~1.2A (WT-Na~V~1.2A: −63.5 ± 0.9 mV, *n* = 15; Na~V~1.2A-S1336Y: −57.7 ± 1.3 mV, *n* = 11, P = 0.0011; Na~V~1.2A-T1623N: −56.7 ± 0.8 mV, *n* = 8, P = 0.0055; Na~V~1.2A-R1882Q: −51.2 ± 1.5 mV, *n* = 14, P \< 0.0001; [Fig. 5, B and D](#fig5){ref-type="fig"}; and [Table 1](#tbl1){ref-type="table"}).

![**Voltage dependence of inactivation of EOEE-associated Na~V~1.2 variants.** **(A and B)** Voltage dependence of inactivation for WT and EOEE-associated Na~V~1.2 variants in the neonatal (A) or adult (B) proteoform. **(C and D)** Values for V~1/2~ of inactivation for WT and EOEE-associated Na~V~1.2 variants in the neonatal (C) or adult (D) proteoform. All data are expressed as mean ± SEM for 8--15 measurements. EOEE-associated variants were compared with WT Na~V~1.2 of the same proteoform using one-way ANOVA, followed by Dunnett's post hoc test. \*\*\*, P \< 0.0001; \*\*, P \< 0.01.](JGP_201912442_Fig5){#fig5}

The kinetics of inactivation ([Fig. 6, A and B](#fig6){ref-type="fig"}) and recovery from inactivation ([Fig. 6, C and D](#fig6){ref-type="fig"}) were indistinguishable between WT and most of the mutant channels regardless of the channel proteoform ([Fig. 6](#fig6){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}). However, both T1623N and R1882Q exhibited a significantly slower entry into the fast inactivated state, as evidenced by the larger time constant for inactivation across a range of voltages in both Na~V~1.2N and Na~V~1.2A ([Fig. 6, A and B](#fig6){ref-type="fig"}).

![**Alternative Na~V~1.2 splicing does not impact the effect of EOEE-associated variants on the kinetics of fast inactivation.** **(A and B)** Voltage dependence of time constants for the onset of fast inactivation for WT and EOEE associated Na~V~1.2 variants in the Na~V~1.2N (A) and Na~V~1.2A (B) isoforms. All data are expressed as mean ± SEM for 8--15 measurements. **(C and D)** Recovery from fast inactivation for WT and EOEE-associated Na~V~1.2 variants in the neonatal (C) and adult (D) isoforms. All data are expressed as mean ± SEM for 8--15 measurements. EOEE-associated variants were compared with WT Na~V~1.2 of the same proteoform using one-way ANOVA, followed by Dunnett's post hoc test. \*, P \< 0.05.](JGP_201912442_Fig6){#fig6}

Integrating and interpreting functional effects of Na~V~1.2 variants {#s8}
--------------------------------------------------------------------

Missense variation in Na~V~1.2 can result in complex changes to channel functional properties. As a result, it can be difficult to understand how these changes sum to a net gain or loss of channel function. To better summarize and integrate the functional differences among channel variants and alternatively spliced proteoforms, we constructed radar plots incorporating peak sodium current density, voltage dependence of activation and inactivation, and the kinetics of inactivation, relative to the WT channel. By plotting the data together, we could better interpret the net effect of a variant on overall channel function. We configured each radar spoke such that points lying outside of the WT plot would be indicative of a gain of function, while points lying within the WT plot would indicate loss of function.

As illustrated in [Fig. 7](#fig7){ref-type="fig"}, all five EOEE-associated mutations showed significant deviations from WT channels in Na~V~1.2N. Most effects observed in the Na~V~1.2N background were consistent with gain of function, whereas one mutation (S1336Y) exhibited a mixture of gain- and loss-of-function defects. However, in the Na~V~1.2A background, the differences in voltage dependence of activation were absent for T236S, E999K, and S13336Y, but the overt differences in voltage dependence of inactivation were present for S1336Y, T1623N, and R1882Q.

![**Radar plots illustrating differences in functional consequences of Na~V~1.2 variants.** Plots were constructed with each spoke arranged such that points lying outside of the WT plot would be indicative of a gain of function, while points lying within the WT plot would indicate a loss of function. The effects of each mutant channel relative to WT are illustrated for Na~V~1.2N (left) and Na~V~1.2A (right) from experimentally collected data.](JGP_201912442_Fig7){#fig7}

Computational modeling of EOEE-associated Na~V~1.2 variants {#s9}
-----------------------------------------------------------

To evaluate how Na~V~1.2 dysfunction affects neuronal excitability, we incorporated the functional properties of each mutation into an established computational model of a cortical pyramidal neuron ([@bib16]; [@bib3]). We created computational models to simulate sodium currents conducted by Na~V~1.2A or Na~V~1.2N, as well as each mutant channel, in both proteoforms. Our models successfully recapitulated the functional differences observed between Na~V~1.2A and Na~V~1.2N ([Fig. 8, A and B](#fig8){ref-type="fig"}), as well the biophysical properties of all mutations ([Fig. 8 C](#fig8){ref-type="fig"}). Importantly, because whole-cell current density is highly variable and may be dependent on cell type, we only modeled changes in voltage-dependent activation and inactivation along with kinetic parameters. For comparison, we modeled the benign familial neonatal-infantile seizures (BFNIS) associated Na~V~1.2 mutation L1563V, using previously published data ([Fig. 8 C](#fig8){ref-type="fig"}; [@bib54]). This mutation has been shown to exhibit biophysical properties that are dependent on splice isoform.

![**Computational modeling of WT Na~V~1.2 splice isoforms.** **(A)** Simulated whole-cell sodium current for Na~V~1.2A (top) and Na~V~1.2N (bottom). **(B)** Voltage dependence of activation and inactivation for simulated sodium currents mediated by the Na~V~1.2N (open circles) and Na~V~1.2A (closed circles). Curves for voltage dependence of inactivation for both isoforms are superimposed. **(C)** Radar plots comparing changes in biophysical parameters of whole-cell sodium current from simulated data for Na~V~1.2N (left) and Na~V~1.2A (right).](JGP_201912442_Fig8){#fig8}

To recapitulate the neuronal environment at different developmental stages, we performed simulations incorporating Na~V~1.2A and Na~V~1.2N at specific ratios based on published data from mouse brain ([@bib12]). To simulate an immature neuron, we developed a model expressing 67% Na~V~1.2N and 33% Na~V~1.2A. Simulations of the WT channels in this model showed that expression of 100% WT Na~V~1.2N or a mixture of Na~V~1.2A and Na~V~1.2N was associated with lower neuronal excitability compared with neurons expressing 100% WT Na~V~1.2A ([Fig. 9](#fig9){ref-type="fig"}). Therefore, while the ∼3-mV difference in voltage dependence of activation between Na~V~1.2N and Na~V~1.2A may appear small, it is sufficient to affect excitability. This is similar to predictions made by other neuronal models, which demonstrate that Na~V~1.2N-expressing neurons have lower excitability compared with neurons expressing WT channels ([@bib54]). However, when we incorporated each EOEE-associated Na~V~1.2 mutation into the immature neuron model with a mixture of Na~V~1.2A and Na~V~1.2N, all but one (T1623N) exhibited overtly greater neuronal excitability ([Fig. 10, A and B](#fig10){ref-type="fig"}). We additionally modeled Na~V~1.2-L1563V, a mutation associated with BFNIS. This mutation evoked a modest enhancement of excitability compared with WT neurons but was not as excitable as most EOEE-associated mutations ([Fig. 10, A and B](#fig10){ref-type="fig"}). Interestingly, although R1882Q is associated with EOEE, it also exhibited a small enhancement of excitability in immature neurons ([Fig. 10, A and B](#fig10){ref-type="fig"}). This suggests that five of these six mutations exert gain-of-function effects strong enough to overcome the normally dampening effect of the Na~V~1.2N on neuronal excitability.

![**Alternative splicing of Na~V~1.2 modulates neuronal excitability.** **(A)** Summary data plotting the number of action potentials against stimulation current for an immature neuron with specific ratios of neonatal/adult Na~V~1.2 isoforms. **(B)** Summary data plotting the number of action potentials against stimulation current for a mature neuron with specific ratios of neonatal/adult Na~V~1.2 isoforms.](JGP_201912442_Fig9){#fig9}

![**Neuronal maturity influences hyperexcitability associated with Na~V~1.2 variants.** **(A)** Action potentials generated in response to a 2.2-nA somatic current stimulation for an immature neuron expressing 67% Na~V~1.2N and 33% Na~V~1.2A throughout the AIS (left), an immature neuron expressing 67% Na~V~1.2N and 33% Na~V~1.2A throughout the AIS, and lower potassium conductance (middle), and a mature neuron expressing 33% Na~V~1.2N and 67% Na~V~1.2A restricted to the proximal AIS (right). **(B)** Summary data plotting the number of action potentials against stimulation current for the immature neuron defined in A. **(C)** Summary data plotting the number of action potentials against stimulation current for the immature neuron with low potassium conductance defined in A. **(D)** Summary data plotting the number of action potentials against stimulation current for the mature neuron defined in A. All simulations assumed heterozygosity.](JGP_201912442_Fig10){#fig10}

As discussed above, patients with Na~V~1.2-associated EOEE often present symptoms within the first days of life ([@bib35]). Previous work has shown that potassium conductance is significantly smaller in mouse neocortical pyramidal neurons immediately after birth and steadily rises during the first weeks of life ([@bib15]). Because we observed relatively mild phenotypes for two EE-associated mutations, T1623N and R1882Q, we hypothesized that a more overt phenotype may be observed at an earlier developmental time point when lower potassium conductance may predispose to hyperexcitability.

To determine the impact of EOEE-associated Na~V~1.2 variants on neuronal excitability in simulated neonatal neurons, we reduced the potassium channel conductance to one-third of that used for the immature neuron described above, while maintaining the sodium channel ratio of 67% Na~V~1.2N and 33% Na~V~1.2A ([Fig. 10](#fig10){ref-type="fig"}). Interestingly, neurons bearing either T236S or E999K, which exhibit large hyperpolarized shifts in the voltage dependence of activation, and S1336Y, which has hyperpolarized activation and depolarized inactivation, were either in a perpetual state of depolarization block (T236S and S1336Y) or entered into depolarization block more readily than WT neurons (E999K; [Fig. 10, A and C](#fig10){ref-type="fig"}). The mutations T1623N and R1882Q, which showed only modest effects on excitability with the full potassium current, showed greater excitability in the neonatal neuron model, being resistant to depolarization block compared with a WT neuron, while the BFNIS mutation exhibited only a modest enhancement of excitability ([Fig. 10 C](#fig10){ref-type="fig"}).

To simulate a mature neuron, we used a published model that restricts Na~V~1.2 expression to the proximal AIS and incorporates Na~V~1.6 into the distal AIS and nodes of Ranvier ([@bib3]). In the mature neuron model, Na~V~1.2 was represented as 33% Na~V~1.2N and 67% Na~V~1.2A. Simulations with WT channels showed that neuronal excitability was not different when 100% Na~V~1.2N, 100% Na~V~1.2A, or a mixture were present ([Fig. 10 B](#fig10){ref-type="fig"}). Further, mature neurons expressing each of the six variants exhibited minor differences in neuronal excitability ([Fig. 10, A and D](#fig10){ref-type="fig"}). Thus, differences in excitability among WT and mutant neurons depend greatly on the developmental context in which those variants are expressed, with hyperexcitability being exacerbated in immature developing neurons ([Fig. 10](#fig10){ref-type="fig"}). Thus, these results predict that the functional effects of EOEE-associated Na~V~1.2 variants will have the greatest impact on neuronal excitability in immature or neonatal neurons, which is consistent with the very early onset of these epilepsies.

Discussion {#s10}
==========

Variants in multiple Na~V~ channel genes are associated with clinically diverse genetic epilepsies and neurodevelopmental disorders. Investigations of the functional consequences of various Na~V~ channel variants have revealed fundamental mechanistic information implicating Na~V~1.1 loss of function in the pathogenesis of Dravet syndrome, and Na~V~1.6 gain of function as a cause for many cases of *SCN8A* epileptic encephalopathy ([@bib57]; [@bib38]; [@bib10]; [@bib51]; [@bib30]). Functional studies have demonstrated a bifurcated pathophysiology of epilepsy and neurodevelopmental disorders associated with *SCN2A* variants. Specifically, Na~V~1.2 gain of function appears typical of EOEE, whereas loss of function seems more prevalent among variants associated with autism spectrum disorder or later-onset epilepsy, although there is significant comorbidity associated with autism spectrum disorders and epilepsy ([@bib3]). However, the fundamental reason for early-onset epilepsy in the setting of *SCN2A* mutation is not completely understood.

In this study, we investigated the contribution of a developmentally regulated alternative mRNA splicing event to the pathogenesis of *SCN2A*-associated epileptic encephalopathy. Previous studies have demonstrated that alternative splicing of *SCN1A*, *SCN2A*, *SCN5A*, and *SCN9A* have important effects on the functional and pharmacological properties of WT and mutant channels encoded by these genes ([@bib25]; [@bib7]; [@bib9]; [@bib40]; [@bib46]). With respect to *SCN2A*, there are functional differences between the two developmentally regulated alternatively spliced Na~V~1.2 isoforms, which may have physiological relevance. The neonatal-expressed Na~V~1.2N exhibits a depolarized voltage dependence of activation ([Fig. 1](#fig1){ref-type="fig"}), and this may dampen excitability in developing neurons.

Our results contrast with previous work that examined functional difference for Na~V~1.2N and Na~V~1.2A proteoforms ([@bib54]). The prior work showed that Na~V~1.2N exhibited faster onset of inactivation and hyperpolarized voltage-dependent inactivation compared with Na~V~1.2A, while we observed only a depolarized shift in activation for Na~V~1.2N. One factor that may explain these differences is the coexpression of β1 and β2 subunits in our study. The β subunits have been shown to alter sodium channel biophysical properties and trafficking ([@bib22], [@bib23]; [@bib6]; [@bib50]). However, both studies concur that the net effect of Na~V~1.2N biophysical properties predicts blunted neuronal excitability. This notion is supported by a previous study of mice engineered to express only Na~V~1.2A that demonstrated greater cortical pyramidal neuronal excitability beginning at postnatal day 3 (P3), and greater susceptibility to pentylenetetrazole-induced seizures beginning at P3 that persisted into adulthood (P53--P75; [@bib11]). Further, our demonstration that incorporating Na~V~1.2N into a compartmental model of a developing cortical pyramidal neuron results in lower firing frequency than neuron models incorporating only the adult proteoform ([Fig. 9](#fig9){ref-type="fig"}) also supports the relevance of *SCN2A* alternative splicing.

Given its physiological importance during early development, we investigated the impact of alternative splicing on a set of EOEE-associated *SCN2A* variants. We tested the hypothesis that the functional consequences of EOEE-associated Na~V~1.2 variants are potentiated in Na~V~1.2N, a phenomenon that may contribute to the early age of onset. The five Na~V~1.2 variants we studied exhibited mostly gain-of-function effects in Na~V~1.2N, but the functional consequences of these variants were more muted when expressed in the context of canonical Na~V~1.2A (adult expressed). Specifically, when expressed in Na~V~1.2N, three of the variants showed greater hyperpolarizing shifts in voltage dependence of activation, while one variant was protected from a depolarizing shift in voltage dependence of inactivation. Given that the splicing event involves a switch of the domain 1 voltage sensor, it is possible that variants with significant shifts in voltage dependence of activation may be disproportionately affected by this alternative splicing event. For Na~V~1.2N-T236S, given no change in single-channel conductance, the increased current density likely results from a hyperpolarized shift in open probability. These observations were supported by computational neuron modeling in which four of the five variants we examined, in which voltage dependence of activation was either hyperpolarized or unchanged, promoted overt hyperexcitability in an immature neuron where Na~V~1.2N is the sole sodium channel in the AIS and the nodes of Ranvier. Furthermore, recent work has suggested that shifts in voltage dependence of activation more strongly influence neuronal excitability than shifts in voltage dependence of inactivation ([@bib28]). Work by [@bib20] showed that a 3-mV shift in voltage dependence of channel activation may lead to up to twice as many sodium channels being recruited due to the steep slope of voltage-dependent channel activation. Thus, even small shifts in voltage dependence of activation may lead to greater recruitment of sodium channels in response to subthreshold events. Consistent with this, T1623N and R1882Q, which show depolarized voltage dependence of inactivation, show only modestly increased excitability.

One variant in our study, R1882Q, has been studied previously by two groups ([@bib4]; [@bib32]). Our primary finding for this variant was a depolarized shift in voltage dependence of inactivation, as well as slower onset of inactivation. The previous studies showed similar effects on these parameters. However, [@bib4] also observed larger whole-cell sodium current compared with the WT channel. Neither our results nor the results of [@bib32] showed larger currents mediated by the R1882Q mutation. Considering that [@bib4] performed experiments in Chinese hamster ovary cells, while our work and the study by [@bib32] used human embryonic kidney--derived cell lines, the most likely explanation for discrepancies between these studies is different cell types.

Other human Na~V~1.2 variants are associated with BFNIS, which exhibits an early onset of pharmacoresponsive epilepsy that typically remits within the first year of life ([@bib54]; [@bib33]). Functional evaluation of BFNIS-associated variants have mostly demonstrated subtle alterations of channel properties, such as small hyperpolarized shifts in voltage dependence of activation or enhanced persistent current, which are consistent with mild gain of function. Two specific *SCN2A* variants, M252V and L1563V, exhibit biophysical defects only when studied in Na~V~1.2N ([@bib54]; [@bib27]). By contrast, one variant (V261M) exhibited functional abnormalities only when expressed in Na~V~1.2A ([@bib27]). These findings were interpreted as evidence against the hypothesis that remission of epilepsy in BFNIS occurs following the developmental switch in *SCN2A* alternative splicing, but that remission is due to higher expression of Na~V~1.6 in these cells, which limits the functional contribution of Na~V~1.2. Consistent with this notion, computational simulations of Na~V~1.2-L1563V demonstrated only modestly increased excitability in immature neurons that normalized in the mature neuron ([@bib54]).

Different functional consequences of mutant Na~V~1.2 channels due to alternative splicing is unlikely to be the only factor accounting for early-onset epilepsy and the subsequent severe neurodevelopmental impairments seen in epileptic encephalopathies. Early neuronal injury and subsequent tissue responses (e.g., reactive gliosis, inflammation) likely contribute to the perpetuation of the seizure-prone state ([@bib29]). A greater proclivity to seizure initiation during early development may be the primary contributing factor of enhanced channel dysfunction of mutant Na~V~1.2N. Indeed, our computational models with reduced potassium conductance show that EOEE-associated variants are prone to hyperexcitability very early in development, likely causing lasting changes to network development.

Many functional and genetic changes occur during the course of neuronal development. As stated above, there is a developmentally regulated switch between the neonatal and adult isoforms of Na~V~1.2 and escalating potassium conductance. However, it is apparent from previous studies that the switch is not complete, with some neonatal isoform persisting into adulthood ([@bib12]). Further, during the course of neuronal development, Na~V~1.2 is replaced in the distal AIS and the nodes of Ranvier by Na~V~1.6 ([@bib27]). Our neuron simulations demonstrated that when EOEE-associated variants are present in both Na~V~1.2N and Na~V~1.2A in a developing neuron, the presence of the less severely affected adult isoform dampens the effect of the neonatal isoform, rendering the neuron less excitable than when the neonatal isoform is the sole Na~V~ channel. Interestingly, when these mutant channels are incorporated into an adult neuron model where Na~V~1.6 is largely responsible for action potential initiation and propagation, we see that no variant dramatically affects excitability. These results suggest that EOEE-associated Na~V~1.2 variants (T236S, E999K, S1336Y, T1623N, and R1882Q) exert their effects very early in development, as is typical for other epileptic encephalopathies such as Dravet syndrome. While replacement of Na~V~1.2 at the AIS by Na~V~1.6 later in development may modulate seizures later in life, it is reasonable to predict that maladaptive changes in neuronal physiology occur in response to dysfunction of Na~V~1.2 early in development.

An important consideration of our work is that we are examining the effect of channel variants in a model of a cortical pyramidal neuron, due to the high expression of Na~V~1.2 throughout the neocortex during development and persistent expression throughout adulthood ([@bib45]). However, there is some evidence that Na~V~1.2 is expressed at the AIS of some interneurons, where it either mediates spontaneous action potential firing associated with basal network inhibition or is critical for network disinhibition ([@bib56]). [@bib56] showed that epileptiform activity induced by magnesium deprivation was exacerbated by selective inhibition of Na~V~1.2 with low concentrations of phrixotoxin-3 in cortical slices. This abnormal activity could be normalized by inhibition of GABA-mediated neurotransmission ([@bib56]). Additionally, Na~V~1.2 is found in unmyelinated axons of neurons from the hippocampal dentate, cerebellar granule cells, and medium spiny neurons of the striatum ([@bib52]; [@bib14]; [@bib34]). Simulations of neuronal excitability suggested that the adult isoforms of two variants we studied, S1336Y and T1623N, are associated with lower neuronal excitability where Na~V~1.2 is the only channel at the AIS, while the neonatal isoform showed either dramatic (S1336Y) or modest (T1623N) hyperexcitability. Because these mutant channels do not influence neuronal excitability in an adult cortical pyramidal neuron, it is possible that complex network effects are set in place by having hyperexcitability during network development. Alternatively, loss of function of small populations of inhibitory interneurons may significantly disrupt excitation/inhibition balance.

In summary, our work has demonstrated that *SCN2A*-associated EOEE may result from channel gain of function that is potentiated in the neonatal Na~V~1.2N proteoform. Further, the developmental stage of the neuron, including Na~V~1.2 splice proteoform ratio, total Na~V~ channel composition, and total potassium conductance, are critical determinants of neuronal excitability and are important considerations for functional evaluation of Na~V~1.2 variants associated with early-onset epilepsy.
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